Clinical phenotype heterogeneity in a family with ε-sarcoglycan gene mutation

• Published in: Neurologia i neurochirurgia polska Vol. 54; no. 1; pp. 33 - 38
• Main Authors: Kaczyńska, Justyna, Jamrozik, Zygmunt, Szubiga, Michał, Rudzińska-Bar, Monika, Janik, Piotr
• Format: Journal Article
• Language: English
• Published: Poland Wydawnictwo Via Medica 01.01.2020
• Subjects: Age; Clinical medicine; Cognition & reasoning; Dyslexia; Dystonic Disorders; Genotype & phenotype; Humans; Mutation; Myoclonus; Neurology; Patients; Phenotype; Rare diseases; Sarcoglycans - genetics; SGCE; DYT11; myoclonus-dystonia syndrome; MDS
• ISSN: 0028-3843; 1897-4260
• DOI: 10.5603/PJNNS.a2020.0005

This paper describes six cases of patients with myoclonus-dystonia syndrome who are members of a family in which an SGCE gene mutation has been confirmed. Myoclonus-dystonia syndrome is a very rare disease, with an incidence in Europe of about 2 in every million. Due to the fact that only a few case reports of this illness are accessible in the literature, the material we collected seems to be valuable for clinical practice. A history was taken, and physical and genetic examinations of the patients were performed. Furthermore, the clinical examination of three patients was video-recorded. The clinical picture of the disease varied significantly between the described individuals, from a healthy carrier of the SGCE mutation to patients presenting mild to moderate symptoms. The differences concerned the age at onset of the disease, the initial symptoms, the intensity of involuntary movements, and the predominant symptoms. In addition to the typical movement disorders which are myoclonus and dystonia, in the described family there was also the coexistence of epilepsy, obsessive-compulsive behaviour, dyslexia, dysgraphia, non-harmonious development of cognitive processes, as well as mild phenotypic features of muscular dystrophy. The mutation (NM_001099401.2:c.806-809delACTG) found in the presented family has not been described elsewhere. Our description of six cases of patients demonstrates the heterogeneity of the natural course of the disease, even in patients with the same mutation. It seems reasonable to regularly examine relatives of patients with myoclonus-dystonia syndrome, who should be observed for involuntary movements as well as non-motor symptoms.